Further, given its key roles in immune regulation and the potential of the Hh pathway to modulate TCR signalling and adaptive immune response [93,94,95], Itch stands a promising therapeutic target in tumours arising from both solid and fluid organ system. The gene discussed is ITCH; the disease is neoplasm.